Infectious Disease Diagnostics Market Size To Reach USD 63.26 Billion By 2035, Driven By Rapid Testing Adoption And Molecular ...

Roche is continuing its return to the RNA space by paying $200 million for the worldwide license to one of SanegeneBio’s ...

The global antibody testing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% between ...

The Global Allergy Diagnostics Market is poised for growth due to rising global allergy incidence, necessitating early disease detection. AI integration and multiplex platforms enhance precision in ...

Roche Holding reported positive Phase II results for its investigational obesity drug CT-388, showing robust efficacy and ...

Roche Holding AG RHHBY announced positive top-line data from a mid-stage study of its investigational candidate, CT-388, being developed for the treatment of obesity. CT-388 is a once-weekly ...

Roche’s cobas® BV/CV PCR assay aims to address frequent misdiagnosis of bacterial vaginosis and Candida vaginitis. The duplex test detects both conditions from one swab with high specificity, enabling ...

Swiss pharmaceutical manufacturer Roche reports phase 2 results for CT-388, pointing to possible expansion in the fast-growing weight-loss market ...

Experts explain how the best retinol serums can benefit your anti-aging skin care routine. Shop TODAY editors also share ...

Techne, bioMerieux, Roche, Lonza Group, Miltenyi Biotec India and More Cell and Gene Therapy Manufacturing QC Market Cell and ...

The agency cleared lab-based and point-of-care infectious disease and clinical chemistry tests as well as software for digital pathology.

Cytespace Africa Laboratories (Cytespace), an MLM Medical Labs company and the only fully CAP-accredited central laboratory in South Africa, has significantly expanded its molecular testing ...